PROFILES - Connect with RTRN Researchers

Angel Mauricio Mayor
Title Epidemiologist
Faculty Rank Associate Professor
Degree MD, MS
Institution Universidad Central Del Caribe
Department Internal Medicine
Clusters Cancer
HIV/AIDS
Infectious and Immunological Diseases
Neurological Disorders and Mental Health
Other
Address
Universidad Central del Caribe
Call Box 60-237
City Bayamon
State PR
Postal Code 00960-6032
Telephone 787-787-8722
Fax 787-787-8733
Email
QR Barcode

Other Positions icon

Title Associate Professor
Institution UPR-SMC
Department Internal Medicine
 
Title Consultant
Institution VA-Caribbean Heathcare System
Department Research
 
Title Junior Member
Institution North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD)

Awards and Honors icon

Gamma of PR Chapter, Universidad Central del Caribe Alpha Omega Alpha
University of Puerto Rico Medical Sciences Campus Magna Cum Lade
National Dean’s List , 15th Annual Edition 1991-1992
National Dean’s List , 16th Annual Edition 1992-1993

Narrative icon

  As a physician and an epidemiologist by training, I have a broad background and experience in the study of rheumatically conditions, including systemic Lupus erythematosus and rheumatoid arthritis, and in the study of HIV/AIDS disease and its related conditions, including hepatitis C infection, cancer, renal disease, and diabetes beside others. I have been an active investigator and a Co-Principal Investigator in the Retrovirus Research Center (RRC) of the Universidad Central del Caribe (UCC) RCMI Program. In addition I am the Co-Principal Investigator of the HIV and Substance Abuse Laboratory Core (HSALC) of the UCC RCMI Program at Bayamon, Puerto Rico. I have been directly implicated with its collaborative research process of the RRC in Puerto Rico, the US and internationally. I have been involved in mentoring junior investigators, including faculty members and internal medicine students. I have been successfully involved in studies generation-implementation, data collection, data management, results dissemination, and study collaborations. I was the principal investigator of one of the pilot project included in the Puerto Rico Comprehensive Center for the study of HIV Disparities (PR-CCHD), grant by the NIH. This project created, implemented and evaluated an educational and counseling intervention directed to reduce hepatitis C virus risk behaviors and co-infection in HIV- infected injecting drug users. I have been involved in the design, creation, and implementation of the course “Health Disparities: A research Approach” that is a collaboration effort of educational institutes in Puerto Rico and US, and the RTRN. I am a member of the Cancer, HIV/AIDS, Neurological Disorders-Mental health, and the Infectious and Immunological Diseases RTRN's clusters. In addition, I am a junior member and part of the steering committee of North American– AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International epidemiology Databases to Evaluate AIDS (IeDEA), since 2010. As a result of my research career I have several peer reviewed publications as first author and co-author in national and international journals.

Programs, Membership, and Biomedical Research icon

BIOMEDICAL RESEARCH BIOMEDICAL - CLINICAL
BIOMEDICAL - CLINICAL BIOMETRICS AND BIOSTATISTICS
BIOMEDICAL - CLINICAL EPIDEMIOLOGY
BIOMEDICAL - CLINICAL PUBLIC HEALTH

Publications icon

  Check NIH Public Access Policy Compliance

Loading
Please wait
1. Desir FA, Lesko CR, Moore RD, Horberg MA, Wong C, Crane HM, Silverberg M, Thorne JE, Rachlis B, Rabkin C, Mayor AM, Mathews WC, Althoff KN. One Size Fits (n)One: The Influence of Sex, Age, and Sexual Human Immunodeficiency Virus (HIV) Acquisition Risk on Racial/Ethnic Disparities in the HIV Care Continuum in the United States. Clin Infect Dis. 2018 Aug 31.
2. Elion RA, Althoff KN, Zhang J, Moore RD, Gange SJ, Kitahata MM, Crane HM, Drozd DR, Stein JH, Klein MB, Eron JJ, Silverberg MJ, Mathews WC, Justice AC, Sterling TR, Rabkin CS, Mayor AM, Klein DB, Horberg MA, Bosch RJ, Eyawo O, Palella FJ. Recent Abacavir Use Increases Risk of Type 1 and Type 2 Myocardial Infarctions Among Adults With HIV. J Acquir Immune Defic Syndr. 2018 May 01; 78(1):62-72.
3. Altekruse SF, Shiels MS, Modur SP, Land SR, Crothers KA, Kitahata MM, Thorne JE, Mathews WC, Fernández-Santos DM, Mayor AM, Gill JM, Horberg MA, Brooks JT, Moore RD, Silverberg MJ, Althoff KN, Engels EA. Cancer burden attributable to cigarette smoking among HIV-infected people in North America. AIDS. 2018 Feb 20; 32(4):513-521.
4. Drozd DR, Kitahata MM, Althoff KN, Zhang J, Gange SJ, Napravnik S, Burkholder GA, Mathews WC, Silverberg MJ, Sterling TR, Heckbert SR, Budoff MJ, Van Rompaey S, Delaney JAC, Wong C, Tong W, Palella FJ, Elion RA, Martin JN, Brooks JT, Jacobson LP, Eron JJ, Justice AC, Freiberg MS, Klein DB, Post WS, Saag MS, Moore RD, Crane HM. Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population. J Acquir Immune Defic Syndr. 2017 08 15; 75(5):568-576.
5. Engels EA, Yanik EL, Wheeler W, Gill MJ, Shiels MS, Dubrow R, Althoff KN, Silverberg MJ, Brooks JT, Kitahata MM, Goedert JJ, Grover S, Mayor AM, Moore RD, Park LS, Rachlis A, Sigel K, Sterling TR, Thorne JE, Pfeiffer RM. Cancer-Attributable Mortality Among People With Treated Human Immunodeficiency Virus Infection in North America. Clin Infect Dis. 2017 Aug 15; 65(4):636-643.
6. Dubrow R, Qin L, Lin H, Hernández-Ramírez RU, Neugebauer RS, Leyden W, Althoff KN, Achenbach CJ, Hessol NA, Modur SP, D'Souza G, Bosch RJ, Grover S, Horberg MA, Kitahata MM, Mayor AM, Novak RM, Rabkin CS, Sterling TR, Goedert JJ, Justice AC, Engels EA, Moore RD, Silverberg MJ. Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada. J Acquir Immune Defic Syndr. 2017 08 01; 75(4):382-390.
7. Muzaale AD, Althoff KN, Sperati CJ, Abraham AG, Kucirka LM, Massie AB, Kitahata MM, Horberg MA, Justice AC, Fischer MJ, Silverberg MJ, Butt AA, Boswell SL, Rachlis AR, Mayor AM, Gill MJ, Eron JJ, Napravnik S, Drozd DR, Martin JN, Bosch RJ, Durand CM, Locke JE, Moore RD, Lucas GM, Segev DL. Risk of End-Stage Renal Disease in HIV-Positive Potential Live Kidney Donors. Am J Transplant. 2017 Jul; 17(7):1823-1832.
8. Shiels MS, Althoff KN, Pfeiffer RM, Achenbach CJ, Abraham AG, Castilho J, Cescon A, D'Souza G, Dubrow R, Eron JJ, Gebo K, John Gill M, Goedert JJ, Grover S, Hessol NA, Justice A, Kitahata M, Mayor A, Moore RD, Napravnik S, Novak RM, Thorne JE, Silverberg MJ, Engels EA. HIV Infection, Immunosuppression, and Age at Diagnosis of Non-AIDS-Defining Cancers. Clin Infect Dis. 2017 02 15; 64(4):468-475.
9. Wong C, Gange SJ, Buchacz K, Moore RD, Justice AC, Horberg MA, Gill MJ, Koethe JR, Rebeiro PF, Silverberg MJ, Palella FJ, Patel P, Kitahata MM, Crane HM, Abraham AG, Samji H, Napravnik S, Ahmed T, Thorne JE, Bosch RJ, Mayor AM, Althoff KN. First Occurrence of Diabetes, Chronic Kidney Disease, and Hypertension Among North American HIV-Infected Adults, 2000-2013. Clin Infect Dis. 2017 02 15; 64(4):459-467.
10. Koethe JR, Jenkins CA, Lau B, Shepherd BE, Wester W, Rebeiro PF, Silverberg MJ, Thorne JE, Gill J, Mayor AM, Willig A, Bosch R, Horberg MA, Justice AC, Sterling TR, Moore RD. Higher Time-Updated Body Mass Index: Association With Improved CD4+ Cell Recovery on HIV Treatment. J Acquir Immune Defic Syndr. 2016 10 01; 73(2):197-204.
11. Klein MB, Althoff KN, Jing Y, Lau B, Kitahata M, Lo Re V, Kirk GD, Hull M, Kim HN, Sebastiani G, Moodie EE, Silverberg MJ, Sterling TR, Thorne JE, Cescon A, Napravnik S, Eron J, Gill MJ, Justice A, Peters MG, Goedert JJ, Mayor A, Thio CL, Cachay ER, Moore R. Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras. Clin Infect Dis. 2016 Nov 01; 63(9):1160-1167.
12. Tossas-Milligan KY, Hunter-Mellado RF, Mayor AM, Fernández-Santos DM, Dworkin MS. Late HIV Testing in a Cohort of HIV-Infected Patients in Puerto Rico. P R Health Sci J. 2016 May 24; 35(2):113-121.
13. Buchacz K, Lau B, Jing Y, Bosch R, Abraham AG, Gill MJ, Silverberg MJ, Goedert JJ, Sterling TR, Althoff KN, Martin JN, Burkholder G, Gandhi N, Samji H, Patel P, Rachlis A, Thorne JE, Napravnik S, Henry K, Mayor A, Gebo K, Gange SJ, Moore RD, Brooks JT. Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000-2010. J Infect Dis. 2016 Sep 15; 214(6):862-72.
14. Althoff KN, Rebeiro PF, Hanna DB, Padgett D, Horberg MA, Grinsztejn B, Abraham AG, Hogg R, Gill MJ, Wolff MJ, Mayor A, Rachlis A, Williams C, Sterling TR, Kitahata MM, Buchacz K, Thorne JE, Cesar C, Cordero FM, Rourke SB, Sierra-Madero J, Pape JW, Cahn P, McGowan C. A picture is worth a thousand words: maps of HIV indicators to inform research, programs, and policy from NA-ACCORD and CCASAnet clinical cohorts. J Int AIDS Soc. 2016; 19(1):20707.
15. Cesar C, Koethe JR, Giganti MJ, Rebeiro P, Althoff KN, Napravnik S, Mayor A, Grinsztejn B, Wolff M, Padgett D, Sierra-Madero J, Gotuzzo E, Sterling TR, Willig J, Levison J, Kitahata M, Rodriguez-Barradas MC, Moore RD, McGowan C, Shepherd BE, Cahn P. Health outcomes among HIV-positive Latinos initiating antiretroviral therapy in North America versus Central and South America. J Int AIDS Soc. 2016; 19(1):20684.
16. Mayor AM, Santiago-Rodriguez EJ, Rios-Olivares E, Tortolero-Luna G, Hunter-Mellado RF. Malignancies Trends in a Hispanic Cohort of HIV Persons in Puerto Rico before and after cART. Int J Cancer Res. 2016; 12(2):92-100.
17. Fred-Jiménez RM, Arroyo-Ávila M, Mayor ÁM, Ríos G, Vilá LM. Clinical Manifestations Associated with Overweight/Obesity in Puerto Ricans with Fibromyalgia Syndrome. J Obes. 2016; 2016:1379289.
18. Rebeiro PF, Gange SJ, Horberg MA, Abraham AG, Napravnik S, Samji H, Yehia BR, Althoff KN, Moore RD, Kitahata MM, Sterling TR, Curriero FC. Geographic Variations in Retention in Care among HIV-Infected Adults in the United States. PLoS One. 2016; 11(1):e0146119.
19. Fernandez-Santos DM, Miranda-Diaz C, Figueroa-Cosme WI, Ramon RO, Mayor AM, Rios-Olivares E, Hunter-Mellado RF. Impact of ASUMA Intervention on HIV Risk Behaviors among Puerto Rican Adolescents. Int J Environ Res Public Health. 2015 Dec 23; 13(1):ijerph13010060.
20. Santiago-Rodríguez EJ, Mayor AM, Fernández-Santos DM, Hunter-Mellado RF. Profile of HIV-Infected Hispanics with Pancytopenia. Int J Environ Res Public Health. 2015 Dec 22; 13(1):ijerph13010038.
21. Rebeiro PF, Althoff KN, Lau B, Gill J, Abraham AG, Horberg MA, Kitahata MM, Yehia BR, Samji H, Brooks JT, Buchacz K, Napravnik S, Silverberg MJ, Rachlis A, Gebo KA, Sterling TR, Moore RD, Gange SJ. Laboratory Measures as Proxies for Primary Care Encounters: Implications for Quantifying Clinical Retention Among HIV-Infected Adults in North America. Am J Epidemiol. 2015 Dec 01; 182(11):952-60.
22. Silverberg MJ, Lau B, Achenbach CJ, Jing Y, Althoff KN, D'Souza G, Engels EA, Hessol NA, Brooks JT, Burchell AN, Gill MJ, Goedert JJ, Hogg R, Horberg MA, Kirk GD, Kitahata MM, Korthuis PT, Mathews WC, Mayor A, Modur SP, Napravnik S, Novak RM, Patel P, Rachlis AR, Sterling TR, Willig JH, Justice AC, Moore RD, Dubrow R. Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. Ann Intern Med. 2015 Oct 06; 163(7):507-18.
23. Koethe JR, Jenkins CA, Lau B, Shepherd BE, Justice AC, Tate JP, Buchacz K, Napravnik S, Mayor AM, Horberg MA, Blashill AJ, Willig A, Wester CW, Silverberg MJ, Gill J, Thorne JE, Klein M, Eron JJ, Kitahata MM, Sterling TR, Moore RD. Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada. AIDS Res Hum Retroviruses. 2016 Jan; 32(1):50-8.
24. Tossas-Milligan KY, Hunter-Mellado RF, Mayor AM, Fernández-Santos DM, Dworkin MS. Late HIV Testing in a Cohort of HIV-Infected Patients in Puerto Rico. P R Health Sci J. 2015 Sep; 34(3):148-54.
25. Koethe JR, Jenkins CA, Lau B, Shepherd BE, Silverberg MJ, Brown TT, Blashill AJ, Anema A, Willig A, Stinnette S, Napravnik S, Gill J, Crane HM, Sterling TR. Body mass index and early CD4 T-cell recovery among adults initiating antiretroviral therapy in North America, 1998-2010. HIV Med. 2015 Oct; 16(9):572-7.
26. Yehia BR, Rebeiro P, Althoff KN, Agwu AL, Horberg MA, Samji H, Napravnik S, Mayer K, Tedaldi E, Silverberg MJ, Thorne JE, Burchell AN, Rourke SB, Rachlis A, Mayor A, Gill MJ, Zinski A, Ohl M, Anastos K, Abraham AG, Kitahata MM, Moore RD, Gebo KA. Impact of age on retention in care and viral suppression. J Acquir Immune Defic Syndr. 2015 Apr 01; 68(4):413-9.
27. Abraham AG, Althoff KN, Jing Y, Estrella MM, Kitahata MM, Wester CW, Bosch RJ, Crane H, Eron J, Gill MJ, Horberg MA, Justice AC, Klein M, Mayor AM, Moore RD, Palella FJ, Parikh CR, Silverberg MJ, Golub ET, Jacobson LP, Napravnik S, Lucas GM. End-stage renal disease among HIV-infected adults in North America. Clin Infect Dis. 2015 Mar 15; 60(6):941-9.
28. Rebeiro PF, Horberg MA, Gange SJ, Gebo KA, Yehia BR, Brooks JT, Buchacz K, Silverberg MJ, Gill J, Moore RD, Althoff KN. Strong agreement of nationally recommended retention measures from the Institute of Medicine and Department of Health and Human Services. PLoS One. 2014; 9(11):e111772.
29. Beachler DC, Abraham AG, Silverberg MJ, Jing Y, Fakhry C, Gill MJ, Dubrow R, Kitahata MM, Klein MB, Burchell AN, Korthuis PT, Moore RD, D'Souza G. Incidence and risk factors of HPV-related and HPV-unrelated Head and Neck Squamous Cell Carcinoma in HIV-infected individuals. Oral Oncol. 2014 Dec; 50(12):1169-76.
30. Ríos G, Estrada M, Mayor AM, Vilá LM. Factors associated with tender point count in Puerto Ricans with fibromyalgia syndrome. P R Health Sci J. 2014 Sep; 33(3):112-6.
31. Santiago-Rodríguez EJ, Mayor AM, Fernández-Santos DM, Ruiz-Candelaria Y, Hunter-Mellado RF. Anemia in a cohort of HIV-infected Hispanics: prevalence, associated factors and impact on one-year mortality. BMC Res Notes. 2014 Jul 08; 7:439.
32. Font YM, Castro-Santana LE, Nieves-Plaza M, Maldonado M, Mayor AM, Vilá LM. Factors associated with regional rheumatic pain disorders in a population of Puerto Ricans with diabetes mellitus. Clin Rheumatol. 2014 Jul; 33(7):995-1000.
33. Althoff KN, Rebeiro P, Brooks JT, Buchacz K, Gebo K, Martin J, Hogg R, Thorne JE, Klein M, Gill MJ, Sterling TR, Yehia B, Silverberg MJ, Crane H, Justice AC, Gange SJ, Moore R, Kitahata MM, Horberg MA. Disparities in the quality of HIV care when using US Department of Health and Human Services indicators. Clin Infect Dis. 2014 Apr; 58(8):1185-9.
34. Hanna DB, Buchacz K, Gebo KA, Hessol NA, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, Korthuis PT, Moore RD, Napravnik S, Patel P, Silverberg MJ, Sterling TR, Willig JH, Collier A, Samji H, Thorne JE, Althoff KN, Martin JN, Rodriguez B, Stuart EA, Gange SJ. Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009. PLoS One. 2013; 8(11):e78952.
35. Mayor AM, Fernández DM, Colón H, Thomas JC, Miranda C, Hunter-Mellado RF. Hepatitis-C multimedia prevention program in poor Hispanic HIV-infected injecting drug users: six months after intervention. J Health Care Poor Underserved. 2013 Nov; 24(4 Suppl):29-37.
36. Maldonado-Martínez G, Fernández-Santos DM, Ríos-Olivares E, Mayor AM, Hunter-Mellado RF. HIV/AIDS in the Puerto Rican elderly: immunological changes between gender and body mass index. J Health Care Poor Underserved. 2013 Nov; 24(4 Suppl):94-105.
37. Dworkin MS, Peterson CE, Gao W, Mayor A, Hunter R, Negron E, Fleury A, Besch CL. Efficacy of a food safety comic book on knowledge and self-reported behavior for persons living with AIDS. PLoS One. 2013; 8(10):e72874.
38. Lucas GM, Jing Y, Sulkowski M, Abraham AG, Estrella MM, Atta MG, Fine DM, Klein MB, Silverberg MJ, Gill MJ, Moore RD, Gebo KA, Sterling TR, Butt AA. Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals. J Infect Dis. 2013 Oct 15; 208(8):1240-9.
39. Negrón AM, Díaz-Correa LM, Gago R, Mayor AM, Martínez A, Vilá S, Vilá LM. Rheumatology practice profiles in teaching and community settings in Puerto Rico: implications to subspecialty training. J Clin Rheumatol. 2013 Mar; 19(2):67-71.
40. Santiago-Casas Y, González-Rivera T, Castro-Santana L, Ríos G, Martínez D, Rodríguez V, González-Alcover R, Mayor AM, Vilá LM. Impact of managed care health insurance system for indigent patients with rheumatoid arthritis in Puerto Rico. Clin Rheumatol. 2013 Jun; 32(6):763-9.
41. Hanna DB, Buchacz K, Gebo KA, Hessol NA, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, Korthuis PT, Moore RD, Napravnik S, Patel P, Silverberg MJ, Sterling TR, Willig JH, Lau B, Althoff KN, Crane HM, Collier AC, Samji H, Thorne JE, Gill MJ, Klein MB, Martin JN, Rodriguez B, Rourke SB, Gange SJ. Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. Clin Infect Dis. 2013 Apr; 56(8):1174-82.
42. Nieves-Plaza M, Castro-Santana LE, Font YM, Mayor AM, Vilá LM. Association of hand or knee osteoarthritis with diabetes mellitus in a population of Hispanics from Puerto Rico. J Clin Rheumatol. 2013 Jan; 19(1):1-6.
43. Dworkin MS, Peterson CE, Gao W, Mayor A, Hunter R, Negron E, Fleury A, Besch CL. Food Safety Knowledge, Beliefs and Behavior of Persons with AIDS: A Multicenter Study. Food Prot Trends. 2013 Jan 01; 33(1):32-41.
44. Rodríguez VE, Rodríguez N, Mayor A, Negrón D. Renal biopsies in Puerto Rico patients with lupus nephritis. Bol Asoc Med P R. 2012 Apr-Jun; 104(2):50-2.
45. Nieves-Plaza M, Ortiz AP, Colón M, Molina MJ, Castro-Santana LE, Rodríguez VE, Mayor AM, Vilá LM. Outcome and predictors of kidney disease progression in Puerto Ricans with systemic lupus erythematosus initially presenting with mild renal involvement. J Clin Rheumatol. 2011 Jun; 17(4):179-84.
46. Mayor AM, Fernández Santos DM, Dworkin MS, Ríos-Olivares E, Hunter-Mellado RF. Toxoplasmic encephalitis in an AIDS cohort at Puerto Rico before and after highly active antiretroviral therapy (HAART). Am J Trop Med Hyg. 2011 May; 84(5):838-41.
47. Miranda C, Fernandez DM, Ramon RO, Velázquez M, Mayor AM, Hunter-Mellado RF. Changes in the socio-demographics, risk behaviors, clinical and immunological profile of a cohort of the Puerto Rican population living with HIV: an update of the Retrovirus Research Center (1992-2008). Bol Asoc Med P R. 2010 Jul-Sep; 102(3):45-51.
48. Castro-Santana LE, Colón M, Molina MJ, Rodríguez VE, Mayor AM, Vilá LM. Efficacy of two cyclophosphamide regimens for the treatment of lupus nephritis in Puerto Ricans: low vs. standard dose. Ethn Dis. 2010; 20(1 Suppl 1):S1-116-21.
49. Mayor AM, Fernández DM, Colón HM, Thomas JC, Hunter-Mellado RE. The effectiveness evaluation of a multimedia hepatitis C prevention program for Hispanic HIV-infected individuals. Ethn Dis. 2010; 20(1 Suppl 1):S1-158-62.
50. Mayor AM, Dworkin M, Quesada L, Ríos-Olivares E, Hunter-Mellado RF. The morbidity and mortality associated with kidney disease in an HIV-infected cohort in Puerto Rico. Ethn Dis. 2010; 20(1 Suppl 1):S1-163-7.
51. Ríos G, Mayor AM. Clinical and sociodemographic features of Puerto Ricans with systemic sclerosis. Ethn Dis. 2010; 20(1 Suppl 1):S1-185-9.
52. Santiago-Casas Y, González-Rivera TC, Castro-Santana LE, Ríos G, Martínez D, Rodríguez VE, González-Alcover R, Mayor AM, Vilá LM. Impact of age on clinical manifestations and outcome in Puerto Ricans with rheumatoid arthritis. Ethn Dis. 2010; 20(1 Suppl 1):S1-191-5.
53. Castillo-Pichardo L, Martínez-Montemayor MM, Martínez JE, Wall KM, Cubano LA, Dharmawardhane S. Inhibition of mammary tumor growth and metastases to bone and liver by dietary grape polyphenols. Clin Exp Metastasis. 2009; 26(6):505-16.
54. Colacioppo-Saavedra R, Rodríguez-Castro J, López JE, Mayor AM. Outcomes after heart valve replacement surgery at the Cardiovascular Center of Puerto Rico and the Caribbean. P R Health Sci J. 2008 Dec; 27(4):368-72.
55. Negrón AM, Molina MJ, Mayor AM, Rodríguez VE, Vilá LM. Factors associated with metabolic syndrome in patients with systemic lupus erythematosus from Puerto Rico. Lupus. 2008 Apr; 17(4):348-54.
56. Mayor AM, Gómez MA, Ríos-Olivares E, Hunter-Mellado RF. AIDS-defining neoplasm prevalence in a cohort of HIV-infected patients, before and after highly active antiretroviral therapy. Ethn Dis. 2008; 18(2 Suppl 2):S2-189-94.
57. Mayor AM, Fernández DM, Colón HM, Thomas JC, Hunter-Mellado RF. The feasibility and acceptability of a multimedia hepatitis C prevention program for Hispanic HIV-infected persons. Ethn Dis. 2008; 18(2 Suppl 2):S2-195-9.
58. Molina MJ, Mayor AM, Franco AE, Morell CA, López MA, Vilá LM. Utilization of health services and prescription patterns among lupus patients followed by primary care physicians and rheumatologists in Puerto Rico. Ethn Dis. 2008; 18(2 Suppl 2):S2-205-10.
59. Molina MJ, Mayor AM, Franco AE, Morell CA, López MA, Vilá LM. Prevalence of systemic lupus erythematosus and associated comorbidities in Puerto Rico. J Clin Rheumatol. 2007 Aug; 13(4):202-4.
60. Vilá LM, Molina MJ, Mayor AM, Cruz JJ, Ríos-Olivares E, Ríos Z. Association of serum MIP-1alpha, MIP-1beta, and RANTES with clinical manifestations, disease activity, and damage accrual in systemic lupus erythematosus. Clin Rheumatol. 2007 May; 26(5):718-22.
61. Báez-Feliciano DV, Quintana R, Gómez MA, Fernández DM, Velázquez M, Olivares E, León Valiente C, Mayor AM, Hunter-Mellado RF. Trends in the HIV and AIDS epidemic in a Puerto Rican cohort of patients: 1992-2005. Bol Asoc Med P R. 2006 Jul-Sep; 98(3):174-83.
62. Mayor AM, Gomez MA, Fernandez DM, Rios-Olivares E, Thomas JC, Hunter RF. Morbidity and mortality profile of human immunodeficiency virus-infected patients with and without hepatitis C co-infection. Am J Trop Med Hyg. 2006 Feb; 74(2):239-45.
63. Vilá LM, Molina MJ, Mayor AM, Peredo RA, Santaella ML, Vilá S. Clinical and prognostic value of autoantibodies in puerto Ricans with systemic lupus erythematosus. Lupus. 2006; 15(12):892-8.
64. Mayor AM, Gómez MA, Ríos-Oliveras E, Hunter-Mellado RF. Mortality trends of HIV-infected patients after the introduction of highly active antiretroviral therapy: analysis of a cohort of 3,322 HIV-infected persons. Ethn Dis. 2005; 15(4 Suppl 5):S5-57-62.
65. Mayor AM, Gomez MA, Rios E, Hunter RF. Recurrent pneumonia mortality risk in a HIV/AIDS Puerto Rican cohort. Cell Mol Biol (Noisy-le-grand). 2003 Dec; 49(8):1199-204.
66. Mayor AM, Vilá LM. Gender differences in a cohort of Puerto Ricans with systemic lupus erythematosus. Cell Mol Biol (Noisy-le-grand). 2003 Dec; 49(8):1339-44.
67. Mayor AM, Gomez MA, Rios E, Hunter RF. Differences between patients with non-Hodgkin's lymphomas in a cohort of HIV/AIDS patients in Puerto Rico. Cell Mol Biol (Noisy-le-grand). 2003 Nov; 49(7):1145-9.
68. Mayor AM, Vilá LM, De La Cruz M, Gómez R. Impact of managed care on clinical outcome of systemic lupus erythematosus in Puerto Rico. J Clin Rheumatol. 2003 Feb; 9(1):25-32.
69. Fernández DM, Gómez MA, Mayor AM, Gómez O, Hunter RF. Survival of AIDS according to injecting drug use among Puerto Rican AIDS patients. Cell Mol Biol (Noisy-le-grand). 2001 Nov; 47(7):1121-7.
70. Mayor AM, Gómez MA, Otero JF, Vilá S, Hunter RF. Pulmonary tuberculosis mortality risks in a cohort of HIV/AIDS patients in Puerto Rico. Cell Mol Biol (Noisy-le-grand). 2001 Nov; 47(7):1143-8.
71. Vilá LM, Mayor AM, Silvestrini IE. Therapeutic response and long-term follow-up in a systemic lupus erythematosus patient presenting with Kikuchi's disease. Lupus. 2001; 10(2):126-8.
72. Vilá LM, Mayor AM, Valentín AH, García-Soberal M, Vilá S. Clinical outcome and predictors of disease evolution in patients with incomplete lupus erythematosus. Lupus. 2000; 9(2):110-5.
73. Vilá LM, Mayor AM, Valentín AH, Rodríguez SI, Reyes ML, Acosta E, Vilá S. Association of sunlight exposure and photoprotection measures with clinical outcome in systemic lupus erythematosus. P R Health Sci J. 1999 Jun; 18(2):89-94.
74. Vilá LM, Mayor AM, Valentín AH, García-Soberal M, Vilá S. Clinical and immunological manifestations in 134 Puerto Rican patients with systemic lupus erythematosus. Lupus. 1999; 8(4):279-86.
75. Fleet GH, Phaff HJ. Glucanases in Schizosaccharomyces. Isolation and properties of an exo-beta-glucanase from the cell extracts and culture fluid of Schizosaccharomyces japonicus var. versatilis. Biochim Biophys Acta. 1975 Dec 18; 410(2):318-32.
76. Noce PS, Utter MF. Decarboxylation of oxalacetate to pyruvate by purified avian liver phosphoenolpyruvate carboxykinase. J Biol Chem. 1975 Dec 10; 250(23):9099-105.
392
77. Schmoldt A, Benthe HF, Haberland G. Digitoxin metabolism by rat liver microsomes. Biochem Pharmacol. 1975 Sep 01; 24(17):1639-41.
10

Abstracts icon

 

Loading
Please wait
1. Lo Re V, Newcomb CW, Carbonari DM, Roy JA, Kitahata MM, Lim JK, Silverberg M, Mayor AM, Horberg MA Cachay E, Hull M, Moore RD, Klein MB, H. Kim N . Conference on Retroviruses and Opportunistic Infections (CROI 2018). Determinants of liver complications among HIV/Hepatitis B-coinfected patients. 2018.
2. Althoff KN, Moore RD, Gill MJ, Hoberg MA, Justice AC, Kitahata M, Kelin M, Desir FA, Mathews WC, Mayor A, Rebeiro PF, Silverberg MJ Gange SJ, and Hogg R. Conference on Retroviruses and Opportunistic Infections (CROI 2018). Life expectancy in key populations of adults with HIV in the US and Canada. 2018.
3. Poteat T, Hanna DB, Rebeito PF, kelin M Silverberg MJ, Eron JJ, Horberg MA, Kotahata MM, Mattocks K, Angel Mayor, Rich A, Moore R, Althoff KN . Conference on Retroviruses and Opportunistic Infections (CROI 2018). Characterizing the HIV continuum of care for transgender women in North America. 2018.
4. Desir FA, Lesko CR, Moore RD, Silverberg MJ, Rebeiro PF, Horberg MA, Kitahata MM, Cristal S, Mayor A, Klein M, Justice AC, Gill MJ and Althoff KN . Conference on Retroviruses and Opportunistic Infections (CROI 2018). Age-dependent racial/ethnic disparities in longitudinal HIV care indicators. 2018.
5. Benson EA, Klein MB, Kitahata M, Moore RD, Lo Re V, Horberg MA, Mayor A, Silverberg MJ, KIM N, Eron JJ, Cachay ER, Hull M, Gange ST, Althoff KN . Conference on Retroviruses and Opportunistic Infections (CROI 2018). Survival after end-stage liver disease in adults with HIV: Finding from the NA-ACCORD. 2018.
6. Desir FA, Lesko CR, Moore RD, Horberg MA, Rebeiro PF, Gill MJ, Kitahata MM, Silverberg MJ, Levison JH, Klein M, Mayor A, Justice AC and Althoff KN. Conference on Retroviruses and Opportunistic Infections (CROI 2018). Trends in unsuppressed HIV RNA after linkage to care among key populations. 2018.
7. AM Mayor, EJ Santiago, DM Fernandez, E Rios-Olivares, RF Hunter-Mellado. 9th International AIDS Society Conference on HIV Science (IAS2017). Mortality Trends in HIV Infected Hispanic During the cART era. 2017.
8. Wong C, Gange SJ, Moore RD, Justice AC, Abraham AG, Gebo KA, Gill JM, Martin JN, Mayor AM, and Althoff KN for the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA . Conference on Retroviruses and Opportunistic Infections CROI, 2017. Trends in Multimorbidity among HIV+ Adults in Clinical Care in the U.S. 2017.
9. Althoff KN, Estrella M, Abraham AG, Gill J, Kitahata MM, Horberg MJ, Hull M, Mayor AM, Palella F, Lucas G for the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA, Conference on Retroviruses and Opportunistic Infections, CROI 2016. The Racial Survival Pardox in HJV + End Stage Renal Disease patients. 2016.
10. Mayor AM. Santiago E, Tortolero G, Rios-Olivares E, Hunter-Mellado R. 21th AIDS Conferences, 2016. Mortality Risk inf Non AIDS Non Hodgkin Lymphomas in HIV Adults in the cART eras. 2016.
11. Wang R, Lucas G, Estrella M, Shlipak M, Harris M, Horberg M, Kitahata M, Mayor AM, Napravnik S, AbrahamA for the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA Conference on Retroviruses and Opportunistic Infections, CROI 2016. The Renal Impact of Tenofovir Disoproxil Fumarate in the NA-ACCORD. 2016.
12. Cesar C, Giganti M, Shepherd B, Moore R, Althoff K, Napravnik S, Mayor A, Mc Gowan C Cahn P.Conference on Retroviruses and Opportunistic Infections CROI 2015 Seattle Washington, February 2015. Outcomes of first ART in Latino population in North American and Latin American. 2015.
13. Althoff KN, Gange SJ, Achenbach C, Jacobson LP, Mayor AM, Silverberg MJ, Justice AC, Moore RD, Yuezhou J, and Gebo KA. Conference on Retroviruses and Opportunistic Infections CROI 2015 . Smoking Outweighs HIV‐related Risk Factors for Non-AIDS-defining Cancers. 2015.
14. Grover S, Jing Y, Goedert J, Silverberg M, Salters K, Horberg M, Achenbach C, Mayor A, Althoff K. International Conference on Malignancies in AIDS and other Acquired Immunodeficiency's (ICMAOC), 2015. Cancer presentation and outcomes of patients with HIV vs. AIDS. 2015.
15. Soto L, Acosta E, Mayor AM, De Jesus L, Estape ES. National Institute on Minority Health and Health Disparities Grantees’ Conference, 2014. Translational Research in Health Disparities Inter-Professional Approach. 2014.
16. Santiago E, Mayor AM, Hunter-Mellado RF. National Institute on Minority Health and Health Disparities Grantees’ Conference, National Harbor, Maryland December 2014. Profile of HIV-Infected Hispanics with Pancytopenia. 2014.
17. Mayor AM, Tortolero G, Zavala D, Rios-Oilvares E, Hunter-Mellado RF. National Institute on Minority Health and Health Disparities Grantees’ Conference, 2014. Head and Neck Squamous Cell Carcinoma trends in a Hispanic HIV cohort. 2014.
18. Mayor AM, Fernandez D, Tortolero G, Zavala D, Rios-Oilvares E, Hunter-Mellado RF. 20th International AIDS conference, 2014. Five Years Cancer incidence and one year mortality risk in a HIV Hispanic cohort before and after combination Antiretroviral Therapy. 2014.
19. Soto L, Acosta E, Mayor AM, Estape, E The 7th Health Disparity Conference, 2014. Interprofessional learning for a translational research approach course. 2014.
20. D M Fernandez, A M Mayor, E Santiago, E Rios-Oliveras, R F Hunter-Mellado. Sexually Trasnitted Infections. HIV/AIDS in a Puerto Rican Women Population: Psychosocial, Risk Behavior, and Lifestyles. 2013; 89(Suppl1):A163.
21. A M Mayor, D M Fernandez, E Rios-Oliveras, D Zavala, R F Hunter-Mellado. Sexually Trasnitted Infections. Malignacies Surveillance in a Hispanic HIV/AIDS Cohort before and after HAART. 2013; 89(Sppl 1):A248.
22. Santiago-Rodriguez E., Fernandez, D., Mayor, A., Hunter-Mellado, R The 13th RCMI International Symposium on Health Disparities, 2012. Prevalence of anemia and associated factors among HIV patients. 2012.
23. Mayor, A., Gerena, Y., Velez, J., Gonzalez, C., Wojna, V., Hunter-Mellado, Robert F. The 13th RCMI International Symposium on Health Disparities, 2012. Insulin receptor secretion levels mortality risk in HIV persons. 2012.
24. Gerena, Y., Mayor, A., Velez, J., Gonzales C., Rios-Olivares, E., Hunter-Mellado R., Wojna, V The 13th RCMI International Symposium on Health Disparities, 2012. Gender differences in Insulin receptor secretion in HIV infection. 2012.
25. Bertoli, A.M., Fajardo, L.D., Mayor, A.M., Franco, A.E., Roman, Y.M., Morell, C.A., & Vila, L.M. . Ann Rheum Dis. Drug prescription pattern among Rheumatoid Arthritis patients of Hispanic ethnicity: impact of age and comorbidities. 2010; 69(3):679.
26. Fajardo-Hermosillo, L.D., Bertoli, A.M., Mayor, A.M., Franco, A.E., Morell, C.A.. Roman, Y.M.,& Vila, L.M. Ann Rheum Dis. Malignancy in a Hispanic population with Rheumatoid Arthritis. 2010; 69(3):370.
27. Santiago-Casas, Y., Gonzalez, T.C., Castro, L.E., Mayor. A.M., Plaza, M.N., & Vila, L.M. . Ann Rheum Dis. Factors associated with outcome measures in Puerto Ricans with Rheumatoid Arthritis. 2010; 69(3): 674.
28. A Mayor, D Fernandez, H Colon, J Thomas, R Hunter-Mellado. Reviews in Antiviral Therapy. An Evaluation of Long-term Effectivenes of a Mulimedia Hepatitis C Prevention Program Aimed at HIV-Infected Hispanics. 2009; 4(1):29.
29. Mayor A, Fernández DM, Rios-Olivares,Hunter-Mellado RF. XVII International AIDS conference, 2008. Gender and Hepatitis C co-infection in a cohort of Hispanic persons living with HIV AIDS. 2008.
30. Mayor A M, Fernández D M, Colón HM, Hunter-Mellado R F. National HIV/AIDS prevention conference. 2007. Multimedia Hepatitis C prevention program for Hispanic HIV infected individuals; First Pre and Post Evaluation. 2007.
31. Mayor A, Fernández D, Colón H and Hunter-Mellado R. Annual International Research Conference on the Role of Families in Prevention and Adapting to HIV/AIDS, 2007. Hepatitis C co-infection knowledge in a cohort of Hispanic HIV infected injecting drug users. 2007.
32. Mayor A, Gómez M, Rios-Olivares E and Hunter-Mellado R. . J Clin Virol. Hepatitis C genotypic profile in 251 HIV/HCV co-infected patients in Puerto Rico. 2006; 36(2):S206. .
33. Mayor A, Gómez M, Rios-Olivares E and Hunter-Mellado R.10th Research Center in Minority Institutions (RCMI) International Symposium on Health Disparities. 2006. Reduction of AIDS defining neoplasms prevalence after HAART. 2006.
34. Mayor A, Fernández D, Gómez M, Colon H and Hunter-Mellado R. 134st APHA Annual Meeting & Exposition. 2006 . Feasibility of a multimedia Hepatitis C prevention program for Hispanic HIV infected individuals. 2006.
35. Molina MJ, Mayor AM, Franco AE, Morell CA, López MA, Vilá LM. Tenth Research Centers in Minority Institutions (RCMI) International Symposium on Health Disparities, 2006. Utilization of health services and prescription pattern among lupus patients followed by primary care physicians and rheumatologists in Puerto Rico. 2006.
36. Mayor A, Fernández D, Gómez M, Colon H and Hunter-Mellado R. 16th International AIDS Conference, August 2006. Multimedia Hepatitis C prevention program for Hispanic HIV infected individuals. 2006.
37. Mayor A, Fernández D, Gómez M and Hunterz-Mellado R. Second International Workshop on HIV and Hepatitis C co-infection, 2006, P 34. Hepatitis C co-infection prevention program for Puerto Rican HIV infected injecting drug users. 2006.
38. Fernández D, Mayor A, Colon H, Miranda C, Soto M and Hunter-Mellado R. 16th International AIDS Conference, 2006 . HCV knowledge among HIV/HCV co-infected patients in Bayamón, Puerto Rico. 2006.
39. Molina M, Mayor A, Franco A, Morell C, Lopez M and Vilá L.10th Research Center in Minority Institutions (RCMI) International Symposium on Health Disparities. December 2006, San Juan, PR. Conference on Retroviruses and Opportunistic Infections CROI, 2017. Prevalence of Systemic Lupus Erythematosus and associated comorbidities in Puerto Rico. 2006.
40. Vilá LM, Cruz JJ, Mayor AM, Ríos-Oliveras E. and Rios Z 9th Research Center in Minority Institutions (RCMI) International Symposium on Health Disparities, 2004. Association of Serum MIP-1α, MIP-1ß and RANTES with Clinical Manifestations, Disease Activity and Damage Accrual in Systemic Lupus Erythematosus. 2004.
41. Mayor AM, Gómez MA, Ríos-Oliveras E. and Hunter-Mellado R 9th Research Center in Minority Institutions (RCMI) International Symposium on Health Disparities, 2004. General Mortality Trends in a Cohort of HIV Infected Persons after the First Decade of Follow up. 2004.
42. AM Mayor, M Gomez, E Rios and RF Hunter 132st APHA Annual Meeting & Exposition. 2004. . Hepatitis C co-infection at first encounter, in cohort of Puerto Rican HIV/AIDS patients. 2004.
43. Mayor AM, Fernández DM, Gómez MA, Colón H. and Hunter-Mellado R 9th Research Center in Minority Institutions (RCMI) International Symposium on Health Disparities, 2004. Hepatitis C Co-infection Prevalence and Prevention in Patients Living with HIV/AIDS. 2004.
44. A Mayor, MA Gomez, E Rios and RF Hunter 131st APHA Annual Meeting & Exposition, 2003 . Hepatitis C co-infection mortality of a HIV/AIDS cohort in Puerto Rico. 2003.
45. LM Vilá and AM Mayor 8th RCMI International Symposium on Health Disparities, 2002. Clinical relevance and prognostic value of autoantibodies in Puerto Ricans with systemic lupus erythematosus. 2002.
46. A Mayor, M Gómez, and Rt Hunter 130th APHA Annual Meeting & Exposition, 2002. . Prevalence in Non-Hodgkin's Lymphoma in a Cohort of HIV/AIDS Patients in Puerto Rico. 2002.
47. A.M. Mayor and L.M. Vilá. 8th RCMI International Symposium on Health Disparities, 2002. Gender differences in clinical manifestations, serological findings and outcome in a cohort of Puerto Ricans with systemic lupus erythematosus. 2002.
48. AM Mayor, M.A. Gómez and R.F. Hunter 8th RCMI International Symposium on Health Disparities, 2002. Differences between non-Hodgkin=s lymphomas in a cohort of HIV/AIDS patients in Puerto Rico. 2002.
49. A.M. Mayor, M.A. Gómez and R.F. Hunter 8th RCMI International Symposium on Health Disparities, 2002. Recurrent pneumonia mortality risk in a cohort of HIV/AIDS patients in Puerto Rico. 2002.
50. Ayala-Torres S, Torres-Ramos C, Vilá LM, Mayor AM, Rosario A, Andujar A 55th Annual Symposiun of Fundamental Cancer Research, “Maintanance of Genomic Integrity”, 2002 . Oxidative mitochondrial DNA damage in systemic lupus erythematosus. 2002.
51. Mayor AM., Vilá LM 129th annual meeting and exposition, American Public Health Association, 2001. Morbidity and mortality variations in SLE patients under different health care delivery system in Puerto Rico. 2001.

Books/Monographs/Textbooks icon

 

Loading
Please wait
1. Mayor, A., Ruiz, Y., Fernandez, D., & Hunter-Mellado R. Immunosupression-Role in Health and Diseases. Neoplasm in HIV/AIDS adult population, before and after highly active antiretroviral therapy. 2012; 433-456.
2. Fernandez-Santos, D., Figueroa-Cosme, W., Miranda, C., Maysonet, J., Mayor-Becerra, A., & Hunter-Mellado R. HIV-Infection, Impact, Awareness and Social Implication of Living with HIV/AIDS. Prevention strategies for HIV infection risk reduction. 2011; 189-200.

Original Articles icon

 

Loading
Please wait
1. Eric A. Engels Elizabeth L. Yanik Willian Wheeler M. John Gill Meredith S. Shiels Robert Dubrow Keri N. Althoff Michael J. Silverberg John T. Brooks Mari M. Kitahata James J. Goedert Surbhi Grover Angel M. Mayor Richard D. Moore Lesley S. Park Anita Rachlis Keith Sigel Timothy R. Sterling Jennifer E. Thorne Ruth M. Pfeiffer for the North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS. Clinical Infectious Diseases, https://doi.org/10.1093/cid/cix392. Cancer-Attributable Mortality Among People With Treated Human Immunodeficiency Virus Infection in North America. 2017; 65(4):636-643.
2. Miranda Díaz, C., Fernández Santos, D., Maldonado Martínez, G., Ramón Rodríguez, R., Velázquez, M., Mayor Becerra, A. M., & Hunter Mellado, R. Boletin Asoc Med PR. Changes in the socio-demographics, risk behaviors and clinical and immunological profile of a cohort of Puerto Ricans living with HIV population: An update of the Retrovirus Research Center (1992-2008). 2010; 102(3):45-51.

Research Resources icon

Funding Opportunities icon

Browse active NIH & NSF funding opportunities, requests for applications (RFAs), and program announcements (PAs)

Publications Timeline

Top MeSH Keywords

Tree Map of Keyword Semantic Groups (Categories)

Left-click a node to move down the tree, right-click the graph to move back up the tree

Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile:
 
Keyword
Last Name
Institution
 
Keywords
HIV Infections
Humans
Female
Male
Adult
See all (283) keywords
See all (7) people See all (29) people Search for (2) people
Feedback

RTRN Collaboration and Professional Networking Feedback